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Viral proteins make extensive use of short peptide interaction motifs to hijack cellular host
factors. However, most current large-scale methods do not identify this important class of
protein-protein interactions. Uncovering peptide mediated interactions provides both a
molecular understanding of viral interactions with their host and the foundation for developing
novel antiviral reagents. Here we describe a viral peptide discovery approach covering 23
coronavirus strains that provides high resolution information on direct virus-host interactions.
We identify 269 peptide-based interactions for 18 coronaviruses including a specific inter-
action between the human G3BP1/2 proteins and an ΦxFG peptide motif in the SARS-CoV-2
nucleocapsid (N) protein. This interaction supports viral replication and through its ΦxFG
motif N rewires the G3BP1/2 interactome to disrupt stress granules. A peptide-based inhibitor
disrupting the G3BP1/2-N interaction dampened SARS-CoV-2 infection showing that our
results can be directly translated into novel specific antiviral reagents.
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RNA viruses such as the Ebola, dengue, and coronavirusescause a variety of diseases and constitute a continuousthreat to public health. The coronaviruses are the largest
single-stranded RNA viruses known and their genomic RNA
encodes around 30 viral proteins1. During infection, each viral
protein performs unique functions and interacts with a range of
cellular protein host factors to allow viral proliferation and
immune escape2–5. Precise disruption of viral-host factor inter-
actions is an attractive strategy for developing novel antiviral
reagents. The advantage of targeting these interactions is that
resistance is less likely to develop and furthermore as the same
host factor can be used by multiple viruses such reagents may
provide broader spectrum activity. Numerous large-scale mass
spectrometry (MS) based interaction screens2,3,5, as well as
CRISPR based screens6–10 have been conducted to uncover host
factor interactions and dependencies for SARS-CoV-2 allowing
repurposing of drugs against human targets11,12. Although these
methods have been transformative in our understanding of
SARS-CoV-2 biology the molecular detail provided by these
methods is not always sufficient to readily transform the results
into novel antiviral reagents. Experimental approaches that would
complement the existing powerful methods and provide a more
detailed view of viral interactions with host factors could accel-
erate the development of new antivirals.
An attractive class of protein interactions that can be inhibited
for therapeutic purposes are viral short linear interaction motifs
(SLiMs) that bind to defined pockets on globular domains of the
host factor13,14. SLiMs are short peptide motifs in unstructured
regions of proteins and typically contain 2–4 amino acid binding
determinants within a 10 amino acid stretch15,16. Viruses
extensively use SLiMs to hijack cellular host factors and SLiMs
can readily evolve through mutations in unstructured regions
allowing viruses to interact with novel host factors17–19. Despite
the importance of SLiMs for understanding viral biology, they are
not uncovered by most current large-scale methods15,16. Pro-
teomic peptide-phage display (ProP-PD) provides the opportu-
nity to identify novel SLiM-based interactions and binding sites at
high resolution20. As shown in a small scale pilot study on
C-terminal peptides of viral proteomes, it can be used to faithfully
capture SLiM-based host-pathogen interactions21. Here we
describe a novel phage-based viral peptide library to map SLiMs
from 23 coronaviruses mediating host factor interactions
(Fig. 1a). This approach allows the simultaneous pan-viral iden-
tification of SLiM-based interactions with high resolution of the
binding sites. We document the power of this approach by
identifying novel SARS-CoV-2 specific SLiM mediated host factor
interactions and directly translate our screening results into novel
mechanistic insights and pinpoint a potential target for antiviral
intervention.
Results
A pipeline for viral SLiM discovery. We exploited recent
developments of the ProP-PD technology20,22 and established a
pipeline to identify RNA virus SLiMs binding to host factors.
Briefly, the pipeline consists of purifying protein domains and
screening these against a novel phage display library displaying
the unstructured parts of viral proteins. Following a number of
selection cycles enriched phages are sequenced to identify the
viral SLiMs binding a specific bait (Fig. 1a). We designed a unique
phage display library (RiboVD library) that tile the unstructured
regions of 1074 viral proteins from 229 RNA viruses, including
SARS-CoV-2, SARS-CoV, MERS-CoV and 20 additional cor-
onavirus strains. This library represents 19,549 unique 16 amino
acid long peptides that are multivalently displayed on the major
coat protein of the filamentous M13 phage. We scanned a
published host factor interactome for the SARS-CoV-2 viral
proteins and recombinantly produced 57 domains from 53 cel-
lular proteins reported to interact with SARS-CoV-22. As tran-
sient SLiM-based protein interactions might be lost during
purifications of viral proteins for subsequent mass spectrometry
analysis, we screened an additional set of 82 peptide-binding
domains. These domains were chosen because they were effi-
ciently expressed and purified in E. coli23 and at least 27 of them
have previously been reported to act as viral-host factors and to
be hijacked by SLiMs from viral proteins. In total, 139 recombi-
nantly expressed and purified human bait proteins (Supplemen-
tary Data 1) were used in selections against the RiboVD library.
Enriched phage pools were analyzed by next-generation sequen-
cing (NGS) to identify viral peptides that bound to the bait. In
light of the ongoing COVID-19 epidemic, we chose to focus on
the interactions mediated by coronavirus proteins in the follow-
ing, which represent 13% of the total number of interactions
identified in the screen. Interaction data for the remaining RNA
viruses will be published elsewhere.
We uncovered 269 putative SLiM-based interactions with 104
interactions identified using the 57 MS identified SARS-CoV-2
host factor baits and 165 interactions identified using the 82
peptide-binding domains. The interactions covers 44 domains
from 42 human proteins and 64 viral proteins from 18
coronavirus strains (Supplementary data 2). Of these, 117
(43%) interaction pairs involved human coronavirus proteins.
We validated 27 interactions using fluorescence polarization
(FP) affinity measurements (Fig. 1b, Supplementary Fig. 1 and
Supplementary Data 3). We visualized the information gener-
ated for human and bat coronavirus proteins in an extensive
network (Supplementary Fig. 2). We also generated a map of the
viral proteins mediating SARS-CoV-2, SARS-CoV and MERS-
CoV interactions with human host factors (Fig. 1c). The map
reveals common as well as unique interactions with host factors
for these three coronaviruses. For instance, NSP14 of all three
strains has a YxxL motif that binds to the clathrin coat adaptor
protein AP2M1 with high affinity (Fig. 1b, Supplementary Fig. 1
and Supplementary Data 3), which may be linked to the
trafficking of the viral protein or blocking of endocytosis of host
proteins24,25. The N-terminal region of the E protein from all
three strains binds to the FERM domains of Ezrin and Radixin
via a recently established [FY]x[FILV] SLiM26. Interestingly, our
data show that the FERM domains also bind to NSP3 of SARS-
CoV and SARS-CoV-2, thus, they can be targeted by distinct
viral proteins. The SARS-CoV NSP3 FERM binding site overlaps
with a [FWY]xx[ILV] binding site for the ATG8 domains of the
autophagy-related MAP1LC3A-C proteins. As an example of
strain-specific interactions, we found that an N-terminal peptide
from the Nucleocapsid (N) proteins from SARS-CoV-2 and
SARS-CoV bound to the NTF2 domain of the homologous
G3BP1 and G3BP2 proteins (G3BPs) with high affinity (Fig. 1b,
c, Supplementary Fig. 1 and Supplementary Data 3). This N
peptide contains an ΦxFG SLiM (where Φ is a hydrophobic
residue) that resembles motifs in USP10 and UBAP2L and in the
alphavirus nsP3 protein known to bind a hydrophobic pocket in
the NTF2 domain of G3BP27–30. The ΦxFG SLiM is also present
in the N proteins from bat beta coronaviruses and consistently
the corresponding bat HKU5 peptide was identified in our
screen (Supplementary Fig. 2 and Supplementary Data 2).
To pinpoint therapeutically relevant host protein-viral SLiM
interactions we screened three of the identified peptide motifs for
antiviral activity. To this end, we generated lentiviral vectors
expressing GFP fused to four copies of one viral SLiM reasoning
that this would inhibit binding of the corresponding full-length
SARS-CoV-2 protein to the specific host factors through
competition. As a control we used GFP fused to SLiMs containing
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mutations in the binding motif. The host proteins targeted by
viral peptides were G3BPs (SARS-CoV-2 N), Ezrin and Radixin
(SARS-CoV-2 E and NSP3), and the MAP1LC3s (NSP3). VeroE6
cells were first transduced with the lentiviruses and 3 days later
infected with SARS-CoV-2 and viral titer determined after 16 h.
This revealed that the G3BP-binding peptide from the N protein
decreased viral titer 3.4-fold (Fig. 2a). To obtain a more potent
inhibition of the SARS-CoV-2 N-G3BP interaction, we used a 25
Fig. 1 A pipeline for viral SLiM discovery. a An overview of the platform for identifying viral SLiMs binding to cellular host factors. b KD values for the
interactions between indicated viral peptides and host proteins. c Network of SLiM mediated interactions between the indicated viral proteins from SARS-
CoV-2 (red), SARS-CoV (purple), and MERS-CoV (yellow) and cellular host factors (blue circles). Light grey connecting line indicates interactions
validated by affinity measurements, the weight of the line represents the affinity of the interaction (thick, 1–10 μM; medium, 11–100 μM; thin, 101–500 μM).
Dark grey lines indicate protein-protein interactions with additional evidence found in the other studies (Supplementary Data 2).
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amino acid residue peptide from Semliki Forest virus (SFV) nsP3
containing two continuous FGDF like SLiMs that has previously
been shown to bind G3PBs with high affinity31. Remarkably, this
peptide binds approximately 10-fold stronger than the SARS-
CoV-2 N peptide to both G3BP1 and G3BP2 (KD= 4 μM vs
KD= 0.3 μM, Fig. 2b and Supplementary Fig. 3a). We constructed
“G3BP inhibitors” (G3BPi) by fusing sequences encoding one or
three copies of wild type (wt) or mutated (ctrl) SFV nsP3 SLiMs
to GFP. As expected, mass spectrometry analysis confirmed that
the major cellular targets of the G3BPi are the G3BPs (Fig. 2c,
Supplementary Fig. 3b and Supplementary Data 4). Furthermore,
expression of the G3BPi wt but not G3BPi ctrl prevented the
binding of SARS-CoV-2 N to G3BP1 in cells (Fig. 2d). Consistent
with these binding and competition data, lentiviral mediated
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expression of the G3BPi in VeroE6 cells potently inhibited SARS-
CoV-2 proliferation after 16 h of infection (Fig. 2a). An effect of
the G3BPi was also evident in assays monitoring viral infection
rates or replication (Fig. 2e, f). In a cell-based transfection assay
monitoring assembly and release of virus-like particles mutating
the G3BP-binding motif in N had no effect (Supplementary
Fig. 3d). Thus, the approach presented here is useful for
identifying important virus-host factor interactions that inhibit
viral proliferation when disrupted.
The N-G3BP1/2 interaction supports SARS-CoV-2 infection.
The above results prompted us to further investigate the N-G3BP
interaction and its function during infection. The coronavirus N
protein is important for viral replication, as well as packaging of
the viral RNA32–34. The G3BPs are multi-functional RNA-bind-
ing proteins best known for their essential roles in innate immune
signaling and the assembly and dynamics of cytosolic stress
granules35–38. Stress granules are large protein-RNA assemblies
formed in response to various stresses and viral infections39–41.
The G3BPs have turned out to be major targets for viral inter-
ference and several viral proteins have been shown to recruit
G3BP1 to support viral replication and/or to inhibit stress
granules formation42. Of note, the herpesviruses and alphaviruses
have been shown to recruit G3BPs by SLiMs having resemblance
to the sequence in N28,43–45. However, a deeper mechanistic
understanding for how viral proteins affect G3BP biology is
missing. Given that the N-G3BP interaction was important for
SARS-CoV-2 infection and presents a novel antiviral strategy we
investigated this interaction in more detail. We first confirmed
that the interaction between N and G3BP1 takes place in SARS-
CoV-2 infected cells (Fig. 2g). We also confirmed the binding of
recombinant full-length N protein to G3BP1 using FP, which
revealed an affinity similar to the N peptide (Fig. 2h). To confirm
the SLiM mediated interaction in cells, we compared the inter-
actome of N wild type (N wt) to an N protein where we mutated
two amino acids in the ΦxFG motif (N 2 A) using label-free
quantitative mass spectrometry. This confirmed a highly specific
N-G3BP1/2 interaction fully dependent on an intact ΦxFG motif
(Fig. 2i, Supplementary Fig. 3c and Supplementary Data 4). Using
a similar approach, we quantitatively compared the interactomes
of the N protein from MERS-CoV with that of N from SARS-
CoV-2, revealing specific binding of G3BPs to N from SARS-
CoV-2 (Fig. 2j and Supplementary Data 4). This is in line with
our observation that the N peptides containing the ΦxFG motif
from SARS-CoV-2 and SARS-CoV bind to G3BPs with high
affinity, while the corresponding MERS-CoV peptide bound
weakly (KD= 2.8 µM vs. KD= 26 µM, Fig. 1b). Similar results
were obtained by Western blot, which also showed that the N
protein from HKU1-CoV did not bind G3BPs, consistent with
the ProP-PD results (Supplementary Fig. 2 and Supplementary
Fig. 3e). Consistently, the ΦxFG motif resulted in the specific co-
localization of mCherry tagged N protein from SARS-CoV and
SARS-CoV-2 to arsenite-induced stress granules in cells expres-
sing YFP-tagged G3BP1 (Fig. 3a).
The N ΦxFG motif affects stress granule formation. Recent
publications have reported that SARS-CoV-2 N induces stress
granule disassembly46,47 but the mechanistic basis of this is
unclear. To investigate the effect of the SARS-CoV-2 N ΦxFG
motif on endogenous stress granule formation we overexpressed
YFP-tagged N wt or N 2 A in HeLa cells and stained for endo-
genous G3BP1 following arsenite treatment. Quantifying the
intensity of cytoplasmic G3BP1 foci in cells positive for YFP
revealed that N WT expression disrupted stress granule forma-
tion more efficiently when the G3BP-binding motif was intact
(Fig. 3b, c). Thus, the N-terminal ΦxFG motif of the N protein
constitutes the main determinant of G3BP-binding and stress
granule disassembly. We next analyzed G3BP1 foci formation and
cellular localization of viral dsRNA in relation to N protein
expression levels in VeroE6 cells after six hours of SARS-CoV-2
infection (Fig. 3d, e). At this timepoint, a mixture of early and
later stage infected cells is observed. In mock-treated cells, we
detected no cells with more than two G3BP1 foci and based on
this we set the background threshold at three G3BP1 foci per cell
(Supplementary Fig. 3f). In infected cells with low levels of N
protein (below 10,000 fluorescent units) a large proportion of
cells had multiple G3BP1 foci (Fig. 3e). In cells with low levels of
N, this protein and viral dsRNA co-localized with G3BP1 to stress
granules (Fig. 3d). However, in cells with high levels of N, protein
only two out of 11 cells had G3BP1 foci above threshold levels.
Collectively our results suggest that low levels of N protein are
insufficient to disrupt stress granule formation and instead N and
viral dsRNA co-localize with G3BP1 in these structures. Once N
concentrations reach a certain threshold, this disrupts stress
granules, and this depends on the ΦxFG motif. A possible
interpretation of these observations is that SARS-CoV-2 takes
advantage of the stress granule RNA machinery during the earlier
stages of infection. Consistently, dsRNA and N co-localize with
G3BP1 foci and when the N-G3BP interaction is inhibited a
reduction of viral replication is observed (Figs. 2f and 3d).
N rewires the G3BP1/2 interactome through the ΦxFG motif.
To understand how N could affect stress granule formation and
G3BP function through the ΦxFG motif we set out to identify
cellular G3BP interactors with similar binding motifs. To this
end, we screened a novel ProP-PD library that displays the
Fig. 2 The interaction between N and G3BP1/2 is important for SARS-CoV-2 infection. a Screen for SARS-CoV-2 antiviral activity of viral peptides
including the G3BP inhibitor G3BPi (p= 0.000013) and N12-27 (p= 0.000005). The amount of SARS-CoV-2 virus released was determined 16 h
postinfection by focus forming assay (n= 8 independent experiments). b Affinity measurements of recombinant G3BP1 NTF2 binding to G3BPi and the
SARS-CoV-2 N peptide (n= two biological duplicates each containing three technical replicates). Shown is a representative plot from one of the
experiments. c Quantitative mass spectrometry comparison of G3BPi wt and ctrl purified from HeLa cells (n= 4 technical replicates). d Purification of myc-
tagged SARS-CoV-2 N expressed in HeLa cells and its interaction with G3BP1 analyzed by western blot. G3BPi wt or ctrl were co-expressed with myc-
tagged N where indicated. Shown is a representative blot from three independent experiments. e Effect of G3BPi on % infected VeroE6 cells during 36 h of
infection (n= 9 independent experiments) *P= 0.0414. f Amount of SARS-CoV-2 RNA measured 16 h postinfection with qPCR at different MOI in VeroE6
cells expressing G3BPi or control inhibitor (n= 6 independent experiments) *P= 0.0291, **P= 0.0029, ***P= 0.0002. g Endogenous G3BP1 was purified
from mock or SARS-CoV-2 infected cells and probed for N. Shown is a representative blot from three independent experiments. h In vitro interaction of
recombinant full-length SARS-CoV-2 N and the NTF2 domain of G3BP1 as measured by fluorescence polarization spectroscopy (n= two biological
duplicates each containing three technical replicates). Shown is a representative plot. i Quantitative mass spectrometry analysis of YFP-tagged SARS-CoV-
2 N wt or 2 A purified from HeLa cells (n= 4 technical replicates). j Quantitative mass spectrometry analysis of YFP-tagged N SARS-CoV-2 and N MERS
purified from HeLa cells (n= 4 technical replicates). Asterisks indicate statistical significance calculated by two-sided unpaired T test (panel a, e, f).
Mean ± SD indicated throughout in the graphs. Source data are provided as a Source Data file.
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Fig. 3 Interaction between SARS-CoV-2 N and G3BP1/2 affects stress granule formation. a Live cell microscopy analysis of HeLa cells co-transfected
with YFP-G3BP1 and mCherry tagged N proteins from the viral strains indicated. b Effect of SARS-CoV-2 N wt and N 2 A on arsenite-induced stress granule
formation as measured by immunofluorescence of endogenous G3BP1. c Quantification of G3BP1 foci intensity from b. Red bar indicates median intensity,
and each circle represents the intensity of one G3BP1 foci. At least five foci from 10 cells were measured. d Immunofluorescence analysis of G3BP1, N and
viral dsRNA in SARS-CoV-2 infected VeroE6 cells 6 h postinfection. e Effect of N levels on G3BP1 foci formation in SARS-CoV-2 infected cells. Each circle
represents one cell analysed automatically from one experiment done in duplicate (n= 51). Microscopy images shown are representatives of three
independent experiments for a and b. Scale bars are 10 μM. Source data are provided as a Source Data file.
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intrinsically disordered regions of the human proteome22 against
the NTF2 domains from G3BP1 and G3BP2. The combined data
set includes 72 peptides from 57 proteins with the majority of
sequences containing a ΦxFG motif (Φx[FILV]), thus resembling
the sequence in the N protein (Fig. 4a and Supplementary
Data 5). Nineteen of the proteins uncovered by the screen are in
core stress granule proteins, including known peptide motifs in
USP10 and UBAP2L, but also peptides from stress granule pro-
teins that have not previously been reported to contain ΦxFG
motifs (Fig. 4a, b). The screen also uncovered a peptide from
Caprin-1, which has been shown to bind G3BPs but does not
match the consensus sequence48 (Fig. 4a). This suggests that
G3BPs serve as major hubs for stress granule biology in part by
interacting with ΦxFG like motifs residing in several stress
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granule components. However, the screen also returned many
peptides in proteins with roles outside of stress granule biology,
such as TRIM25 and IRF7 (antiviral interferon signaling)42, and
DDIT3 (endoplasmic reticulum stress)49. FP measurements were
used to confirm binding between the purified NTF2 domain of
G3BP2 and several identified peptides originating from TRIM25,
DDIT3, UBAP2L, Caprin-1, USP10, and PRRC2B (Fig. 4c and
Supplementary Fig. 4a). Furthermore, we biochemically validated
a number of the G3BP-binding motifs in the context of the full-
length proteins (Supplementary Fig. 4b). Caprin-1 and UBAP2L
co-localized with G3BP1 in stress granules after arsenite treat-
ment in a manner dependent on intact SLiMs (Supplementary
Fig. 4c). Conversely, no stress granule localization was observed
for TRIM25 and DDIT3 (Supplementary Fig. 4c) further sup-
porting the notion that the G3BPs also have cellular roles beyond
stress granule biology50.
The N protein is a highly expressed viral protein51 during
infection so we hypothesized that it would compete with host cell
proteins containing ΦxFG SLiMs for binding to G3BPs. Consis-
tently, FP measurements revealed competition between the N ΦxFG
peptide and all of the 7 peptides we tested for interaction with
G3BP2 (Fig. 4c). Next, immunopurifications of full-length YFP-
tagged TRIM25, DDIT3, Caprin-1, and UBAP2L in the presence of
either a N wt peptide or a N 3A peptide where the ΦxFG motif is
mutated to AxAA were performed. As expected, the N wt peptide
disrupted interactions to G3BP1 thus validating a direct competition
between the N ΦxFG peptide motif and four G3BP-binding
proteins (Fig. 4d). The observed competition between the viral N
ΦxFG peptide and UBAP2L for binding to G3BP1 is particularly
interesting since UBAP2L is required for stress granule assembly
through a direct interaction to the G3BPs via its ΦxFG like
motif27,29. This suggests a mechanistic basis for the ability of the N
protein to inhibit stress granule formation.
Given the high levels of N during infection, we speculated
that it could mediate a general rewiring of the G3BP
interactome through its ΦxFG motif. To test this on a global
scale, we purified G3BP1-YFP from HeLa cells and added either
N wt or the N 3 A mutated peptide as competitors for cellular
proteins. Quantitative label-free mass spectrometry allowed us
to determine the proteins being specifically displaced by the N
wt peptide (Fig. 4e and Supplementary Data 4). This revealed
specific displacement of 59 proteins, including several core
stress granule components. In addition, the N peptide also
displaced a large number of nuclear pore complex components,
heat shock chaperones of the Hsp70 family and proteins of the
ASC-1 and CTLH complexes. Except the CTLH components,
all of these proteins have been reported to localize to stress
granules27,52,53. The displacement of nucleoporins from G3BP1
by the N peptide suggests that FG motifs, which are abundant
in nucleoporins54 might recruit them to stress granules through
direct interaction to the NTF2 domain of the G3BPs.
Consistently, two ΦxFG like motifs from nucleoporins were
selected in the G3BP ProP-PD screen (Fig. 4a, b and
Supplementary Data 5). Importantly, Nup62, which we identify
in our MS competition screen (Fig. 4e) has been shown to be
required for efficient SARS-CoV-2 infection3. It is possible that
N displaces Nup62 from G3BPs to make it accessible for other
viral processes. Together, we show that the N protein modulates
the G3BP1/2 host interactome through its ΦxFG motif by
competing with numerous cellular ΦxFG containing proteins.
Our G3BP motif and mass spectrometric screens provide a rich
resource for the future dissection of basic stress granule biology
and G3BP signaling in general.
Discussion
Collectively, we describe a potentially therapeutic relevant inter-
action between the ΦxFG SLiM in SARS-CoV-2 N and the G3BP
proteins. Our results reveal that the N protein during infection
hijacks G3BPs to viral replication centers likely to facilitate
replication and possibly other aspects of viral RNA metabolism.
The disruption of stress granules at later stages of infection could
also dampen the cellular antiviral response. Consistent with
this idea we identify ΦxFG motifs in TRIM25, MEX3C and IRF7
that are key components of the G3BP-RIG-1 antiviral interferon
pathway42,55–57.
By screening the intrinsically disordered regions of 229 RNA
viruses against a host factor in one we uncovered both common
principles shared by several viruses as well as interactions specific
for a given strain. We show that the SLiMs can be screened for
antiviral activity to pinpoint therapeutically relevant interactions.
Given the high-resolution binding site information provided by
the ProP-PD, this can guide the development of agents targeting
these interactions. Peptide-based inhibitors are highly specific but
a challenge for peptides as compared to small molecules is their
poor pharmacokinetic properties, which may be improved
through peptide modifications58–60. The clinical use of the HIV
peptide inhibitor enfuvirtide (T20) demonstrate that the use of
peptides represents a viable strategy for the development of
therapeutic antiviral agents61, although the T20 peptide does not
need to cross the cell membrane to elicit an effect. As far as we
know, no cell-permeable peptide is used in the clinic, but there
are several ongoing clinical trials62. The ligands described here
may thus represent potential starting points for the development
of antiviral agents.
Our approach is easily applied to other relevant host factors
and the library can be readily updated to incorporate novel RNA
viruses emerging in the future. In this work, 139 recombinant
host protein baits were produced for the RiboVD library screen.
Still, this set of baits only represents a small fraction of host
protein domains expected to recognize virally encoded SLiMs.
Thus, the production of recombinant protein baits in consider-
able numbers and of sufficient purity constitute a bottleneck of
the ProP-PD approach. Nevertheless, we foresee that this
approach can be a powerful tool for future investigations of virus
interactions with cellular host factors and for developing novel
antivirals.
Fig. 4 N competes with cellular proteins for binding to G3BP1/2 through its ΦxFG motif. a Schematic of the position-specific scoring matrix ΦxFG for
G3BP NTF2 domains and sequence alignment of coronavirus peptides and selected human G3BPs ligands found through ProP-PD. b Network of a select set
of human SLiM-based interactions of the G3BPs found through ProP-PD. Light grey line indicates interactions validated by affinity measurements
(Supplementary Data 3), the weight of the line represents the affinity of the interaction (thick, 1–10 μM; medium, 11–100 μM; thin, 101–500 μM). Dark grey
lines indicate protein-protein interactions with additional reported evidence. c The SARS-CoV-2 ΦxFG N peptide competes with the indicated peptides for
G3BP2 binding in vitro (n= two biological duplicates each containing three technical replicates). Shown is a representative plot. Error bars expressed as
mean ± SD. d The N ΦxFG peptide but not a control peptide competes with TRIM25, CAPRIN1, DDIT2 and UBAP2L for binding to G3BP1 in cells. Shown is a
representative blot from three independent experiments. e G3BP1-YFP was affinity purified from HeLa cells in the presence of either a SARS-CoV-2 ΦxFG
N wt or N 3 A peptide and analysed by quantitative mass spectrometry. The volcano plot shows the two-sided unpaired T test results for all quantified
proteins based on four technical replicates per condition.
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Methods
RiboVD library design—defining the RNA virus search space. The RiboVD
library was designed using a previously described design pipeline22. Following this
pipeline, the first step was to define the RNA virus search space. The search space
was defined as the UniProt reference proteomes of the mammalian and avian RNA
viruses (Riboviria; taxonomic identifier: 2559587) and a representative proteome
from RNA virus clades without a reference proteome (A complete list of the viral
strains in the library is available at http://slim.icr.ac.uk/phage_libraries/
rna_viruses/species.html). This set of 229 viral strains was analysed to define
intracellular and intrinsically disordered protein regions. First, the UniProt defined
transmembrane and the extracellular regions of transmembrane proteins were
removed. Next, the intrinsically disordered region of the remaining search space
was defined using 3 approaches: (i) Surface Accessibility Scores from structures of
the protein; (ii) Surface Accessibility Scores from homology mapped structures;
and (iii) Disorder Predictions using IUPred63.
RiboVD library design—library peptide definition. The intracellular and intrin-
sically disordered protein regions of the RNA viruses were processed to produce a
tiled peptide library. A 16 residue window was scanned across the proteins of the
search space until it reached a peptide where at least eight of the 16 amino acids are
defined as occurring in an intrinsically disordered region based on the rules above.
The window was then shifted forward by four amino acids to produce a library of 16
amino acid peptides overlapping by 12 amino acids. Cytoplasmic loops of length eight
or greater that are predicted as disordered were retained. In addition, to avoid issues
with unpaired cysteines on the phage coat, all cysteines were replaced with alanines.
The resulting library contained 19,549 unique peptides from 1074 proteins (i.e., the
numbers are based uncleaved polyprotein) in 229 viral strains across 211 families. The
library design contains 4172 coronavirus peptides mapping to 192 proteins from
23 strains including SARS-CoV-2, SARS-CoV, and MERS-CoV-2. The details of the
library designs including the viral strains, proteins, peptides and statistics are available
at http://slim.icr.ac.uk/phage_libraries/rna_viruses/species.html.
RiboVD library design—library oligonucleotide definition. Each peptide from
the design was reverse translated into oligonucleotides optimising for codon usage
for E. coli by stochastically choosing codons to match codon usage in E. coli. In the
cases where no overlapping peptide existed for a peptide in the design, a peptide
was at the N-terminus or a peptide was at the C-terminus: two distinct oligonu-
cleotides encoding the same peptide were added. Next, primers for annealing to the
phagemid (5’ CAGCCTCTTCATCTGGC and 3’ GGTGGAGGATCCGGAG) were
added to each end of the oligonucleotide design. Finally, oligonucleotides were
checked for SmaI restriction sites (GGGCCC or CCCGGG) or self-
complementarity of greater than seven contiguous nucleotides and redesigned if
necessary. The final library included 23,271 oligonucleotides encoding 19,549
unique peptides in 1074 proteins/polyprotein from 229 viruses 211 in viral families.
RiboVD phage library construction. The designed oligonucleotide library was
obtained from a commercial provider (Genscript) and used to construct the
RiboVD phage library that display the encoded peptides on the major coat protein
P8 of the M13 phage following a published protocol20,22. In brief, the oligonu-
cleotide library was used as the template for 15 cycles amplification cycles of PCR
amplification (98 °C for 10 sec, 56 °C for 15 sec, and 72 °C for 10 sec) using Phusion
polymerase (Thermo Scientific) and primers complementary to the constant
annealing regions flanking the designed library sequences. The PCR product was
purified using a nucleotide removal kit (Qiagen), phosphorylated using T4 poly-
nucleotide kinase (Thermo Scientific) for 1 h at 37°C and annealed to phagemid
ssDNA (90 °C for 3 min, 50 °C for 3 min, and 20 °C for 5 min). dsDNA was syn-
thesized using T7 DNA polymerase (Thermo Scientific) and T4 DNA ligase
(Thermo Scientific) at 20°C for 16 h. The dsDNA was purified from a 1% agarose
gel and electroporated into E.coli SS320 (Lucigen) electrocompetent cells pre-
infected with M13KO7 helper-phage (ThermoFisher). The phages were allowed to
propagate for 24 h in 2YT (10 g yeast extract, 16 g tryptone, 5 g NaCl per L)
medium. The phage was precipitated from the supernatant by the addition of 1/5th
volume of 20% PEG8000/2.5 M NaCl and centrifugation at 27,000 × g for 20 min.
The phage pellets were dissolved in phosphate-buffered saline (PBS, 137 mM NaCl,
2.7 mM KCl, 95 mM Na2HPO4, 15 mM KH2PO4 pH 7.5). The resulting phage
library was re-amplified and stored at −80°C in the presence of 10% glycerol.
Protein purification. E.coli BL21-Gold(DE3) (Agilent Technology) transformed
with the plasmids encoding the His-GST-tagged proteins (Supplementary Data 1)
were grown in 500 mL 2YT at 37˚C until an OD600 between 0.6 and 0.8. Protein
expression was induced with 1 mM isopropyl ß-D-1-thiogalactopyranoside (IPTG)
and allowed to proceed for 20 h at 18 °C. The bacteria were harvested by cen-
trifugation (4500 × g, 10 min). Proteins were batch purified using Glutathione
Sepharose™ 4 Fast Flow Media (Cytiva,) or Ni2+ IMAC (Ni Sepharose™ 6 Fast Flow,
Cytiva) following the manufacturer’s protocols. The purity of the proteins was
validated via SDS-PAGE.
Proteins used for FP affinity measurements were expressed and purified in
larger-scale bacterical cultures (at least 8 × 500 mL 2YT). His-GST-tagged G3BP1
and G3BP2 were used directly for affinity measurements after dialysis. For the
other proteins, the tag was removed by cleaving with HRV 3 C protease or
thrombin, and further purified by reverse IMAC or by using a HiTrap
Benzamindine FF (HS) (Cytiva) before being dialysed to a suitable buffer for FP
affinity measurements (50 mM phosphate buffer, pH 7.5, and 1–2 mM reducing
agent (DTT or TCEP)), except for the FERM domains of Radixin and Ezrin
(20 mM HEPES pH 7.3, 150 mM NaCl, 3 mM DTT).
ProP-PD selections and NGS data analysis. Phage display selections against the
immobilized bait proteins were performed in triplicate selections for four rounds of
selection. The RiboVD library constructed in this study was used in selections
against 139 human bait proteins purified (Supplementary data 1). The GST-tagged
NTF2 domains of G3BP1 and G3BP2 were further used in selections against a
phage library that encodes the intrinsically disordered regions of the human pro-
teome (the second generation human disorderome displayed on the major coat
protein P8 (HD2 P8))22. GST-tagged bait protein or GST (10 µg in 100 µL PBS)
was immobilized in 96-well Flat-bottom Immunosorp MaxiSorp plates (Nunc,
Roskilde, Denmark) for 18 h at 4°C. Wells were blocked with 200 µL BSA (0.5% in
PBS) and then washed 4 times with 200 µL PT (PBS+ 0.05% (v/v) Tween20). The
phage library (1011 phage in 100 µL PBS per well) was transferred to the GST-
coated wells. After 1 h the library was transferred to bait protein-coated wells. After
2 h, unbound phage were removed and the wells were washed with 5 ×200 µL PT.
Bound phage were eluted with 100 µL log phase E.coli OmiMAX (30 min at 37°C),
and the bacteria were then hyperinfected with 109 M13KO7 helper-phage per well
(45 min at 37° C). The hyperinfected bacteria (100 µL) were transferred into 1 mL
2xYT supplemented with 100 µg carbenicillin, 30 µg kanamycin, 0.3 mM IPTG and
grown over night at 37°C for 18 h. Bacteria were pelleted by centrifugation (2000× g
for 10 min), and phage supernatants were transferred into a fresh 96-well plate and
pH adjusted using 1/10 volume 10x PBS. The remaining bacteria were heat-
inactivated for 10 min at 65°C. The resulting phage pools were used as in-phage for
the next day of selection.
The peptide-coding regions of the naive RiboVD phage library prior to any
selection and the binding enriched phage pools (5 µL) were PCR amplified and
barcoded using Phusion High-Fidelity polymerase (Thermo Scientific) for 22
cycles, using a dual barcoding strategy64. PCR products were confirmed through
2% agarose gel electrophoresis stained with GelRed, using a 50 bp marker (BioRad).
The amount of the PCR products were normalized using Mag-bind Total Pure
NGS (Omega Bio-tek) before pooling the samples. The resulting amplicon pool was
further purified from a 2% agarose gel (QIAquick Gel extraction Kit Qiagen) with
GelRed staining and eluted in TE (10 mM Tris-HCl, 1 mM EDTA. pH 7.5). The
sample was analyzed using Illumina MiSeq v3 run, 1x150bp read setup, 20% PhiX
by the NGS-NGI SciLifeLab facility. Results were processed using in-house custom
Python scripts described previsouly22. Reads with an average quality score of 20 or
more were kept, and their adapter regions and barcodes were determined allowing
a maximum of 1 mismatch per adapter and/or barcode. The unambiguously
identified reads were demultiplexed and their adapter and barcode regions were
trimmed. Reads from each selection experiment were then translated into amino
acid sequences and the number of counts for each unique peptide was determined.
Peptide mapping and annotation. An RNA virus search database was added to
the PepTools (http://slim.icr.ac.uk/tools/peptools/) web server22, a tool developed
for the annotation of protein regions built on the framework of the PSSMSearch
tool65. The selected peptide sequences were mapped to the viral or human pro-
teomes with PepTools and annotated with information of the bait and prey (known
interaction or shared localisation and functional terms). To assess the quality of
RiboVD library we analyzed the coverage percentage of the phage library over the
library design using the NGS results of non-challenged naive library phage ali-
quotes. 95.5% of the peptide sequences designed to be in the library were confirmed
by the NGS analysis of the naive phage library.
Analysis of the ProP-PD selection data. Following our recently outlined ProP-
PD data analysis approach22 four metrics were used to rank the peptides i) NGS
read counts, ii) peptide occurrence in replicated selections, iii) number of over-
lapped peptides, iv) motif match. The four metrics were then combined into a
single score called ‘Confidence level’ forming 3 categories: high (4 metric criteria
matched); medium (2 to 3 criteria matched); and low (only 1 metric is matched).
Due to the relatively small size of the RiboVD library, the coronavirus dataset was
further filtered for target-specific ligands (occurring in less than 10 unrelated
selections) (Supplementary data 2). The G3BPs HD2 P8 data were combined and a
joint confidence score was calculated (Supplementary data 5). The peptide data
were combined with available information on stress granule localized proteins from
mass spectroscopy of purified mammalian stress granules27,52,66 and from other
studies based on the information listed in the HIPPIE database67. Each ProP-PD
selected peptide was annotated with the above data and a count of the number of
sources of evidence of stress granule localisation.
PPI network visualization. Network’s visualization was done using Cytoscape68
using the data provided in Supplementary data 2 and 5.
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FP affinity determinations. FP experiments were carried out using a SpectraMax
iD5 multimode microplate reader (Molecular Devices) using a black half area
96-well plate (Corning, USA #3993) with a total volume of 50 μL. The settings used
were 485 nm for excitation and 535 nm for emission.
Peptides were from GeneCust (France) with a purity of over 95%. FITC-labeled
peptides were dissolved in dimethyl sulfoxide (DMSO). Unlabelled peptides were
dissolved in phosphate buffer (50 mM phosphate buffer pH 7.5 and 1–2 mM
reducing agent DTT or TCEP). All measurements were performed at least in
triplicates. For saturation binding experiment, proteins were serially diluted in the
plate with phosphate buffer in a volume 25 μL, and then supplemented with a
master mix of 10 nM FITC-labeled peptide in phosphate buffer. In the
displacement assay, a master mix was prepared containing 10 nM FITC-labeled
peptide with the protein of interest at a concentration 4 x the KD determined
through direct binding. Twenty-five mitroliter of this displacement master mix was
added to unlabeled peptides, which were serially diluted in the plate in 25 μL
phosphate buffer.
The data were analysed with GraphPad Prism version 9.0.0 for MacOS
(GraphPad Software, San Diego, California USA, www.graphpad.com). The
saturation binding data were fitted to a quadratic Eq. (1):
Y ¼ A 
pept þ X þ KD 
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
pept þ X þ KD




in which Y is the observed signal, pept is the constant concentration of the FITC-
labeled probe peptide, X is the varying protein concentration, A is the signal
amplitude divided by the peptide concentration and B is the plateau value obtained
for the unbound probe peptide.
The data of the displacement experiment were fitted to a sigmoidal dose-
response (2):
Y ¼ Bottomþ Top Bottom
1þ 10 logIC50Xð Þ*HillSlopeÞ
ð2Þ
in which Y is the observed signal, X is the log of the variable concentration of the
unlabeled peptide, and the Top and Bottom are the plateau values obtained for the
protein-bound FITC-labeled probe peptide (Top) and the unbound probe peptide
(Bottom).
Cell culture, virus, and reagents. HeLa and HEK293 cells were maintained in
DMEM GlutaMAX containing 100 U/mL penicillin, 100 mg/ml streptomycin, and
10% FCS (all from Thermo Fisher Scientific). Stable HEK cell lines were generated
using the T-Rex doxycycline inducible Flp-In system (Invitrogen) and cultivated
like HeLa cells with the addition of 5 μg/mL Blasticidin and 100 μg/mL Hygro-
mycin B. Caco2 cells were kept in MEM (Gibco™, 11095-080) supplemented with
20% FBS, penicillin-streptomycin solution (Sigma, P4333), 1 mM sodium pyruvate
(ThermoScientific™, 11360039), and nonEssential amino acids (Gibco™, 11140035).
VeroE6 cells were cultured in DMEM (Sigma) supplemented with 5% fetal
bovine serum (FBS), 100 U/mL of penicillin and 100 μg/mL streptomycin (Gibco).
The patient isolate SARS-CoV-2/01/human/2020/SWE accession no/GeneBank no
MT093571.1, was provided by the Public Health Agency of Sweden. SARS-CoV-2
passage number 4 was cultured and titrated in VeroE6 cells. E. coli DH5α were
maintained and propagated using standard microbiological procedures. The
following drug concentrations were used: sodium arsenite 0.5 mM, doxycycline
10 ng/ml unless otherwise stated.
Expression constructs and cell line generation. Standard cloning techniques were
used throughout. All N proteins and variants were generated by gene syntesis
(Geneart). To generate the YFP-G3BPi inhibitor, the double FGDF motif from
Semliki Forest virus nsP3 (RTTFRNKLPFTFGDFDEHEVDALASGITFGDFDDVL)
or a control inhibitor (RTTFRNKLPATAGDFDEHEVDALASGITAGDADDVL)
were fused to the C terminus of YFP by cloning the DNA encoding this into the
pcDNA5/FRT/TO vector (Invitrogen). DNA encoding the G3BPi sequences was
purchased from GeneArt, Life Technologies. All constructs were fully sequenced. The
following point mutations were introduced using quick-change mutagenesis to
uncouple binding to G3BP: TRIM25 (F406A G407A), DDIT3 (F10A G11A),
CAPRIN-1 (Y370S N371K F372S I373T), UBAP2L (F518L F523G). See supple-
mentary primer table for names and sequences of primers used in this study. Detailed
mutagenesis and cloning strategies are available upon request.
Lentivirus production, transductions, and virus infection. Transfer plasmids for
lentiviral transduction were ordered from GenScript. To generate transfer
plasmids, four copies of inhibitory peptide (three copies for the Semilikiforest
peptide) or control peptides with the binding motifs mutated were fused to
C-terminus of EGFP and cloned to pLJM1-EGFP vector (David Sabatini lab,
Addgene plasmid #19319).
Lenti-X 293 T cells (Takara bio) grown in a 100 mm plate format were co-
transfected with 4.5 μg psPAX2 (Didier Trono lab, Addgene plasmid #12260),
500 ng pMD2.G (Didier Trono lab, Addgene plasmid #12259) and 5 μg of transfer
plasmid per plate using polyethylenimine (Merck) as transfection reagent. At 24 h
post-transfection, the medium was replaced with DMEM GlutaMAX containing
100 U/ml penicillin, 100 mg/ml streptomycin, and 10% FCS. Viral supernatant was
harvested at 72 h post-transfection, filtered through a 0.22 μm low protein-binding
syringe filter and frozen at −80 °C.
For transductions, VeroE6 or HEK cells were seeded into greiner CELLSTAR®
96-well plates or 6-well plates (VWR) containing lentivirus in DMEM containing
2% FBS and 1 μg/mL polybrene, and incubated for 72 h. Transduced VeroE6 cells
were infected with SARS-CoV-2 using the indicated multiplicity of infection
(MOI). Virus was detected using the same method as for viral titration except for
using donkey antirabbit IgG Alexa Fluor 555 secondary antibody (Invitrogen,
A32794). Nuclei were counterstained by DAPI. The number of infected cells were
determined by quantifying cells positive for SARS-CoV-2 nucleocapsid using a
TROPHOS Plate RUNNER HD®. The number of infected cells were determined by
dividing the SARS-CoV-2 nucleocapsid count by the DAPI count and presented as
percentage infection of in relation to cells expressing control peptide.
Viral titration. The virus was diluted in ten-fold dilutions and added to VeroE6
cells followed by 1 h incubation at 37°C and 5% CO2. After 24 h of infection, the
inoculum was removed and cells were fixed in 4% formaldehyde for 30 min, per-
meabilized in PBS 0.5% trition-X-100 and 20 mM glycine. The virus was detected
using primary monoclonal rabbit antibodies directed against SARS-CoV-2
nucleocapsid (Sino Biological Inc., 40143-R001), and secondary antirabbit HRP
conjugated antibodies (1:2000, Thermo Fisher Scientific). Viral foci were then
stained by incubation with TrueBlue peroxidase substrate for 30 min (KPL,
Gaithersburg, MD).
Antibodies. The following antibodies were used at the indicated dilutions: c-Myc
(1:1000, Santa Cruz Biotechnology, sc-40), rabbit anti-G3BP1 (WB; 1:1000, Cell
Signaling Technology, #17798 S), mouse anti-G3BP1 (IF; 1:1000, Abcam, ab56574),
GFP-Booster_Atto488 (IF 1:300, ChromoTek), mouse anti-GFP (WB, 1:1000,
Roche, 11814460001), rabbit anti-GFP (WB; 1:5000, in-house), rabbit anti-SARS-
CoV-2 nucleocapsid(WB 1:2500; IF 1:500; Sino Biological Inc., 40143-R001),
mouse APC-conjugated antibody directed against dsRNA J2 (IF 1:200, Scicons,
10010500) mouse anti-3xFlag M2 (WB 1:25000, Sigma, F1804), rabbit anti-Tubulin
(WB 1:4000, Abcam, ab6046), antirabbit SARS-CoV-2 nucleoprotein (1:500;
Invitrogen, MA5-29981), antimouse G3BP1 (1:1000; SantaCruz Biotechnology, sc-
365338), antimouse GAPDH (1:1000; SantaCruz Biotechnology, sc-47724), donkey
antirabbit IgG (Invitrogen, A32794), goat antirabbit HRP conjugated antibody
(WB 1:2000 or 1:5000, Thermo Fisher Scientific, 31460), goat antimouse HRP
conjugated antibody (WB 1:5000, Thermo Fisher Scientific, 31430), goat antimouse
Alexa Fluor 546 (IF 1:1000, Invitrogen, A-11003), donkey antirabbit Alexa555
(IF 1:500, Thermo Fisher Scientific, a31572), donkey antimouse Alexa488 (IF 1:500,
Thermo Fisher Scientific, a21202), goat IRDye 800CW anti-Mouse IgG (WB
1:10000, Li-Cor Biosciences, 926-32210), goat IRDye 800CW anti-Rabbit IgG
(WB 1:10000, Li-Cor Biosciences, 926-32211), goat IRDye 680RD anti-Mouse IgG
(WB 1:10000, Li-Cor Biosciences, 926-68070), goat IRDye 680RD anti-Rabbit IgG
(WB 1:10000, Li-Cor Biosciences, 926-68071).
RNA isolation, cDNA synthesis, and qPCR. Total RNA was isolated from cells and
400 ng was used to synthesize cDNA using High Capacity cDNA Reverse Tran-
scription Kit (Applied Biosystems) according to the manufacturer’s instructions.
GAPDH transcripts were detected by RT2 qPCR Primer Assay (Qiagen, Cat# 330001
PPQ00249A) and the qPCRBIO SyGreen Mix Hi-ROX kit (PCRBIOSYSTEMS),
SARS-CoV-2 transcripts were detected using forward (GTCATGTGTGGCGGTTC
ACT) and reverse (CAACACTATTAGCATAAGCAGTTGT) primers and probe
(FAM-CAGGTGGAACCTCATCAGGAGATGC-BHQ) and the qPCRBIO Probe
Mix Hi-ROX kit (PCRBIOSYSTEMS). qPCR was run using a StepOnePlus fast real-
time PCR system (Applied Biosystems).
Live cell imaging. Live-cell analysis was performed on a Deltavision Elite system
using a × 40 oil objective with a numerical aperture of 1.35 (GE Healthcare). The
DeltaVision Elite microscope was equipped with a CoolSNAP HQ2 camera
(Photometrics). Cells were seeded in eight-well Ibidi dishes (Ibidi) and before
filming, the media was changed to Leibovitz’s L-15 (Life Technologies). Appro-
priate channels were recorded for the times indicated. For transient transfections,
DNA constructs were transfected into HeLa cells using lipofectamine 2000 (Life
Technologies) 24 h prior to analysis.
Immunoprecipitations. Cells were lyzed in lysis buffer (150 mM NaCl, 50 mM Tris
pH 7.4, 1 mM EDTA, 1 mM DTT, 0.1% NP40) supplemented with protease and
phosphatase inhibitors (Roche) for 25 min on ice. Lysates were cleared for 15 min
at 20000 x g and incubated with 20 μL preequalibrated GFP-trap or Myc-trap beads
(ChromoTek) as indicated for 45 min at 4 °C. Following 3 washes with lysis buffer,
the beads were either eluted in 25 μL 2x LDS sample buffer (Novex, Life Tech-
nologies), boiled for 5 min, separated by SDS-PAGE and analyzed by Western
blotting (LI-COR ImageStudio v. 3.1.4 used for analysis) with the indicated anti-
bodies or subjected to quantitative mass spectrometry as described in the AP-MS
section. For peptide competition experiments the indicated peptides were added to
cell lysates for 30 min at 4 °C before incubated with GFP-trap beads. For
uncropped Western blots, see Supplementary Fig. 5.
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Immunoprecipitation of SARS-CoV/SARS-CoV2/MERS-CoV N proteins. Two
15 cm3 dishes were seeded with HeLa cells at 20% confluency. On the following
day, cells were transfected with 2.5 mg YFP-myc-N protein or YFP control plas-
mids. Cells were collected after 48 h and lysed in 900 mL lysis buffer: 100 mM
NaCl, 50 mM Tris pH7.4, 0,1% IGEPAL (NP40), 1 mM DTT supplemented with
protease (Complete EDTA Free mini:Roche) and phosphatase (PhosStop: Roche)
inhibitor tablets. Lysates were sonicated with Bioruptor for 10 cycles: 30 s ON, 30 s
OFF intervals at 4 °C and cleared at 20000 × g for 45 min. The cleared lysate was
incubated with pre-equilibrated GFP-Trap beads for 1 h at 4 °C and rotation. Three
washes with 1 mL wash buffer: 150 mM NaCl, 5 0 mM Tris pH 7.4, 0.05% IGEPAL
(NP40), 5% glycerol, 1 mM DTT, followed by one wash with 1 mL basic wash
buffer: 150 mM NaCl, 50 mM Tris pH 7.4, 5% glycerol. The supernatant was
discarded, and beads were stored at −20 °C before prepared for the MS analysis, or
separated by SDS-PAGE followed by Western blot analysis.
G3BP1 immunoprecipitation in SARS-CoV-2 infected cells. Caco2 cells were
seeded in a 6-well plate and incubated 48 h at 37 °C. Cells were infected with SARS-
CoV-2 at a MOI of 1 and incubated for 48 h. Cells were, then, lysed in 300 µL of
Immunoprecipitation lysis buffer (20 mM HEPES, pH 7.4, 110 mM potassium
acetate, 2 mM MgCl2, 0.1% Tween 20, 1% Triton X-100, 0.5% sodium deox-
ycholate, 0.5 M NaCl) and sonicated for 2 min at 75% amplitude. The lysate was
cleared by centrifugation 10 min at 14000 x g and 40 µL of the lysate was aliquoted
for further analysis by SDS-PAGE followed by western blot analysis. The remaining
lysate was used for immunoprecipitation studies. Shortly, 250 µL of cell lysate was
incubated with 800 ng of G3BP1 antibody (SantaCruz, #sc-365338) for 15 min. The
lysate was incubated overnight with 20 µL of protein G Mag Sepharose™ (#28-9613-
79; GE Healthcare) and washed with lysis buffer. Proteins were eluted in 40 µL of
glycine (pH 2.2) and equilibrated with 10 µL Tris (pH 9.1). NuPAGE LDS sample
buffer was added to the lysate and immunoprecipitation samples and samples were
boiled for 10 min at 95 °C. Samples were analysed by SDS-PAGE followed by
western blotting. For western blot analysis, proteins were transferred to a PVDF
membrane (0.45 µm, BioRad). The membrane was blocked 1 h at room tempera-
ture in 5% milk. Membranes were incubated for 1 h with primary antibodies:
SARS-CoV-2 nucleoprotein (1:500), G3BP1 (1:1000) and GAPDH (1:1000); fol-
lowed by incubation with secondary antibody: antimouse HRP conjugated
(1:30,000). Membranes were incubated with developing reagents and imaged with
GelDoc imaging station.
Immunofluorescence microscopy. For immunofluorescence microscopy, HeLa
cell lines were seeded in eight-well Ibidi dishes (Ibidi) and transfected with the
indicated constructs. Twenty-four hours after transfection cells were treated with
0.5 mM sodium arsenite for 30 min to induce the formation of stress granules and
subsequently fixed in 4% paraformaldehyde in PBS. Cells were blocked in 3% BSA
in PBS-T for 30 min before incubation with GFP-Booster _Atto488 (1:300;
Chromotek), or mouse anti-G3BP1 in 3% BSA in PBS-T for 1 h at room tem-
perature. Unbound primary antibodies were removed by washing four times for
5 min in PBS-T at room temperature followed by incubation with secondary
antibodies (Alexa Fluor 546; 1:1000; Invitrogen) and DAPI for 45 min. Ibid dishes
were then washed four times for 5 min in PBS-T. Z stacks 200 nm apart were
recorded on a microscope (DeltaVision Elite) using a 40 × oil objective lens
(numerical aperture 1.35) followed by deconvolution using SoftWoRx. The fluor-
escent intensity of stress granule signals was quantified by drawing a circle closely
around stress granule signals and the intensity values from the peak continuous
stacks were subtracted from the background of neighboring areas.
VeroE6 cells were seeded in eight-well chamber slides (Sarstedts) and infected
with SARS CoV-2 for 6 h. Cells were fixed with 4% formaldehyde, quenched with
10 mM glycine, and permeabilized with PBS and 0.5% Triton X-100. Thereafter,
cells are incubated with primary antibodies against SARS-CoV-2 nucleocapsid
((1:500) Sino Biological Inc., 40143-R001) and G3BP1 ((1:500) Abcam, ab56574)
followed by incubation with conjugated secondary antibodies antirabbit Alexa555
and antimouse Alexa488 (1:500, Thermo Fisher Scientific). Then cells were stained
with an APC-conjugated antibody directed against dsRNA J2 ((1:200) Scicons
10010500, the antibody was conjugated using APC Conjugation Kit - Lightning-
Link® (ab201807)). Nuclei were detected with DAPI (diluted 1:1500), coverslips
were mounted and samples were analyzed using a Zeiss 710 (Carl Zeiss,
Oberkochen, Germany) confocal microscope with a 63x oil objective (Zeiss) and
ZEISS ZEN Imaging Software. For quantification of G3BP1 foci and nucleocapsid,
images were obtained using a Leica SP8 Laser Scanning Confocal Microscope with
a 63x oil objective (Leica) and Leica Application Suit X software (LAS X, Leica). A
total of 10 images containing 51 cells from infected samples and 14 cells from mock
samples were quantified using ImageJ/Fiji. An area outline was drawn for each cell
and the total fluorescent signal of nucleoprotein and amount of stress granules/area
was counted using “analyze particles”. The threshold was set equal for all
measurements and cells with saturated signal was excluded. All data were adjusted
for background signal.
Assembly assay. pcDNA3.1 expression plasmids coding for the structural pro-
teins of SARS CoV-2, Spike (S D614), Membrane (M) (was a gift from Jeremy
Luban (Addgene plasmid #158074 and 158078; http://n2t.net/addgene:158078;
RRID: Addgene_158078)), Envelope 3xFlag (pGBW-m4252867 was a gift from
Ginkgo Bioworks & Benjie Chen (Addgene plasmid # 153626; http://n2t.net/
addgene:153626; RRID: Addgene_153626) and pcDNA5/FRT/TO Myc SARS
CoV2 N and N 2 A was transfected into HEK293T cells using GeneJuice (Novagen,
Darmstadt, Germany) following the manufacturer’s protocol (12 μg of DNA/
sample in total). Cells and Virus-Like Particles (VLPs) were collected 24 h after
transfection. Cells were lysed (0.5 M Tris-HCl pH 8, 1M NaCl, 1% Triton X-100)
and supernatant of transfected cells was collected, and concentrated by ultra-
centrifugation (100,000 × g, 90 min 4 °C, SW41, Beckman Coulter, Brea, CA). The
pellet was resuspended in reducing Laemmli SDS-PAGE sample buffer. Proteins
were separated with SDS-PAGE and Western blot analysis was performed using
antibodies against SARS CoV-2 nucleocapsid, 3xFlag M2 (Sigma, F1804) and
tubulin (Abcam, ab6046).
Affinity purification and mass spectrometry (AP‐MS). Partial on-bead digestion
was used for peptide elution from GFP-Trap Agarose (Chromotek). Briefly, 100 μL
of elution buffer (2M urea; 2 mM DTT; 20 μg/mL trypsin; and 50 mM Tris, pH
7.5) was added and incubated at 37 °C for 30 min. Samples were alkylated with
25 mM CAA and digested overnight at room temperature before the addition of
1% trifluoroacetic acid (TFA) to stop digestion. Peptides were desalted and purified
with styrene-divinylbenzene reversed‐phase sulfonate (SDB‐RPS) StageTips.
Briefly, two layers of SDB‐RPS were prepared with 100 μL wash buffer (0.2% TFA
in H2O). Peptides were loaded on top and centrifuged for 5 min at 500× g, and
washed with 150 μL wash buffer. Finally, peptides were eluted with 50 μL elution
buffer (80% ACN and 1% ammonia) and vacuum‐dried. Dried peptides were
dissolved in 2% acetonitrile (ACN) and 0.1% TFA in water and stored at −20 °C.
LC-MS analysis. Liquid chromatography-mass spectrometry (LC-MS) analysis
was performed with an EASY-nLC-1200 system (Thermo Fisher Scientific) con-
nected to a trapped ion mobility spectrometry quadrupole time-of-flight mass
spectrometer (timsTOF Pro, Bruker Daltonik GmbH, Germany) with a nano-
electrospray ion source (Captive spray, Bruker Daltonik GmbH). Peptides were
loaded on a 50 cm in-house packed HPLC-column (75 µm inner diameter packed
with 1.9 µm ReproSilPur C18-AQ silica beads, Dr. Maisch GmbH, Germany).
Peptides were separated using a linear gradient from 5-30% buffer B (0.1% formic
acid, 80% ACN in LC-MS grade H2O) in 43 min followed by an increase to 60%
buffer B for 7 min, then to 95% buffer B for 5 min and back to 5% buffer B in the
final 5 min at 300 nL/min. Buffer A consisted of 0.1% formic acid in LC-MS grade
H2O. The total gradient length was 60 min. We used an in-house made column
oven to keep the column temperature constant at 60 °C.
Mass spectrometric analysis was performed essentially as described in Brunner
et al.69 in data-dependent (ddaPASEF) mode. For ddaPASEF, 1 MS1 survey TIMS-
MS and 10 PASEF MS/MS scans were acquired per acquisition cycle. Ion
accumulation and ramp time in the dual TIMS analyzer was set to 100 ms each and
we analyzed the ion mobility range from 1/K0 = 1.6 Vs;cm-2 to 0.6 Vs;cm-2.
Precursor ions for MS/MS analysis were isolated with a 2 Th window for m/z < 700
and 3 Th for m/z > 700 in a total m/z range of 100-1.700 by synchronizing
quadrupole switching events with the precursor elution profile from the TIMS
device. The collision energy was lowered linearly as a function of increasing
mobility starting from 59 eV at 1/K0 = 1.6 VS;cm-2 to 20 eV at 1/K0 = 0.6 Vs cm-2.
Singly charged precursor ions were excluded with a polygon filter (out of control,
Bruker Daltonik GmbH). Precursors for MS/MS were picked at an intensity
threshold of 1.000 arbitrary units (a.u.) and resequenced until reaching a ‘target
value’ of 20.000 a.u taking into account a dynamic exclusion of 40 s elution.
Data analysis of proteomic raw files. Mass spectrometric raw files acquired in
ddaPASEF mode were analyzed with MaxQuant (version 1.6.7.0)70,71. The Uniprot
database (2019 release, UP000005640_9606) was searched with a peptide spectral
match (PSM) and protein level FDR of 1%. A minimum of seven amino acids was
required including N-terminal acetylation and methionine oxidation as variable
modifications and cysteine carbamidomethylation as fixed modification. Enzyme
specificity was set to trypsin with a maximum of two allowed missed cleavages. The
first and main search mass tolerance was set to 70 ppm and 20 ppm, respectively.
Peptide identifications by MS/MS were transferred by matching four-dimensional
isotope patterns between the runs (MBR) with a 0.7-min retention-time match
window and a 0.05 1/K0 ion mobility window. Label-free quantification was per-
formed with the MaxLFQ algorithm72 and a minimum ratio count of two.
Bioinformatic analysis of LC-MS data. Proteomics data analysis was performed
with Perseus73 and within the R environment (https://www.r-project.org/). Max-
Quant output tables were filtered for ‘Reverse’, ‘Only identified by site modifica-
tion’, and ‘Potential contaminants’ before data analysis. Missing values were
imputed after stringent data filtering and based on a normal distribution (width =
0.3; downshift = 1.8) prior to statistical testing. For pairwise proteomic compar-
isons (two-sided unpaired t test), we applied a permutation-based FDR of 5% to
correct for multiple hypothesis testing including an s0 value74 of 0.1.
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-021-26498-z ARTICLE
NATURE COMMUNICATIONS |         (2021) 12:6761 | https://doi.org/10.1038/s41467-021-26498-z | www.nature.com/naturecommunications 11
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
The mass spectrometry proteomics data have been deposited to the ProteomeXchange
Consortium via the PRIDE partner repository75 with the dataset identifier PXD025410
available at: http://proteomecentral.proteomexchange.org/cgi/GetDataset?ID=PXD025410.
A complete list of the viral strains in the library is available at http://slim.icr.ac.uk/
phage_libraries/rna_viruses/species.html. Transmembrane and extracellular regions of
transmembrane proteins were identified using UniProt (https://www.uniprot.org). The
details of the library designs including the viral strains, proteins, peptides and statistics are
available at http://slim.icr.ac.uk/phage_libraries/rna_viruses/species.html. For peptide
mapping and annotation, an RNA virus search database was added to the PepTools (http://
slim.icr.ac.uk/tools/peptools/) webserver. The identity of proteins localizing to stress
granules was retrieved from the HIPPIE database (http://cbdm-01.zdv.uni-mainz.de/
mschaefer/hippie/). Intrinsic disorder predictions were made using IUPred (https://
iupred3.elte.hu/). Raw data is provided as source data for Figs. 2a, e, f, 3c, e and
Supplementary Figs. 3f and 4c. Source data are provided with this paper.
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